Smruthi Organics has informed that the Board of Directors of the Company at its meeting held on 11th March 2020 declared an Interim Equity Dividend of 30%, Rs 3 per equity share of Rs 10 each for the financial year 2019-20. Pursuant to Regulation 42 of the SEBI (LODR) Regulations 2015 the record date of 20th March 2019 earlier fixed for purpose of payment of interim equity dividend and informed by its intimation dated 11th March 2020 stands cancelled. Further, revised record date for purpose of determining the names of the equity shareholders, who shall be entitled to receive payment towards Interim Equity Dividend of the Company for the financial year 2019-20 is Saturday, 21st March 2020. The payment of the interim equity dividend would be made to the eligible shareholders on or before 31st March, 2020.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1679.85 |
| Dr. Reddys Lab | 1333.05 |
| Cipla | 1305.85 |
| Zydus Lifesciences | 947.10 |
| Lupin | 2340.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: